A Comprehensive Review of Chalcones in Dual-Targeted Therapeutics for the Treatment of Parkinson's Disease.
INTRODUCTION The design of novel therapeutic entities for neurodegenerative diseases, particularly Parkinson's disease, remains a major challenge in medicinal chemistry. Current treatment strategies primarily rely on symptomatic management, often involving levodopa in combination with catechol-O-methyltransferase (COMT...